Narwhal Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$312K Sell
4,519
-6,750
-60% -$466K 0.03% 143
2025
Q1
$763K Sell
11,269
-240
-2% -$16.3K 0.07% 114
2024
Q4
$517K Sell
11,509
-15,585
-58% -$700K 0.05% 127
2024
Q3
$1.7M Sell
27,094
-9,358
-26% -$588K 0.15% 84
2024
Q2
$2.15M Sell
36,452
-2,127
-6% -$126K 0.2% 78
2024
Q1
$3.08M Sell
38,579
-14,013
-27% -$1.12M 0.3% 69
2023
Q4
$4.15M Sell
52,592
-6,521
-11% -$515K 0.45% 58
2023
Q3
$4.13M Sell
59,113
-19
-0% -$1.33K 0.5% 53
2023
Q2
$4.09M Buy
59,132
+10,905
+23% +$754K 0.48% 56
2023
Q1
$3.58M Sell
48,227
-963
-2% -$71.6K 0.45% 58
2022
Q4
$4.58M Buy
49,190
+4,997
+11% +$466K 0.61% 46
2022
Q3
$4.22M Buy
44,193
+2,730
+7% +$260K 0.61% 49
2022
Q2
$3.84M Buy
41,463
+54
+0.1% +$5K 0.53% 52
2022
Q1
$4.19M Sell
41,409
-9,236
-18% -$935K 0.49% 55
2021
Q4
$5.23M Buy
50,645
+293
+0.6% +$30.2K 0.59% 47
2021
Q3
$4.27M Buy
50,352
+29
+0.1% +$2.46K 0.54% 51
2021
Q2
$4.2M Buy
50,323
+1,255
+3% +$105K 0.53% 53
2021
Q1
$3.69M Sell
49,068
-1,569
-3% -$118K 0.5% 52
2020
Q4
$3.46M Sell
50,637
-19,286
-28% -$1.32M 0.49% 56
2020
Q3
$4.08M Buy
69,923
+7,772
+13% +$454K 0.66% 48
2020
Q2
$4.04M Sell
62,151
-2,485
-4% -$161K 0.7% 46
2020
Q1
$3.84M Buy
64,636
+13,999
+28% +$831K 0.83% 43
2019
Q4
$3.76M Sell
50,637
-735
-1% -$54.6K 0.69% 48
2019
Q3
$3.24M Sell
51,372
-15,380
-23% -$970K 0.65% 49
2019
Q2
$3.64M Sell
66,752
-2,534
-4% -$138K 0.75% 43
2019
Q1
$3.74M Buy
69,286
+23,841
+52% +$1.29M 0.81% 40
2018
Q4
$2.98M Buy
45,445
+17,835
+65% +$1.17M 0.74% 47
2018
Q3
$2.17M Buy
27,610
+450
+2% +$35.4K 0.48% 69
2018
Q2
$1.75M Buy
27,160
+9,848
+57% +$634K 0.41% 79
2018
Q1
$1.08M Buy
17,312
+12,312
+246% +$766K 0.25% 100
2017
Q4
$363K Sell
5,000
-25,565
-84% -$1.86M 0.08% 128
2017
Q3
$2.49M Sell
30,565
-1,505
-5% -$122K 0.62% 56
2017
Q2
$2.58M Buy
32,070
+15,780
+97% +$1.27M 0.67% 53
2017
Q1
$1.28M Buy
+16,290
New +$1.28M 0.36% 84